Danaher Corporation (NYSE:DHR – Get Free Report) has earned an average rating of “Moderate Buy” from the twenty-two research firms that are presently covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a hold rating and nineteen have issued a buy rating on the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $238.65.
DHR has been the topic of a number of recent analyst reports. Evercore increased their target price on Danaher from $225.00 to $232.00 and gave the stock an “outperform” rating in a research note on Tuesday, April 21st. Wolfe Research reduced their target price on Danaher from $260.00 to $230.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 8th. Wells Fargo & Company reduced their target price on Danaher from $240.00 to $212.00 and set an “equal weight” rating on the stock in a research note on Wednesday, April 22nd. TD Cowen reduced their target price on Danaher from $245.00 to $240.00 and set a “buy” rating on the stock in a research note on Wednesday, April 22nd. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Danaher in a research note on Thursday, January 29th.
Check Out Our Latest Stock Report on DHR
Insider Activity at Danaher
Hedge Funds Weigh In On Danaher
Institutional investors have recently made changes to their positions in the company. Main Street Group LTD purchased a new position in shares of Danaher during the first quarter valued at $25,000. JPL Wealth Management LLC purchased a new position in Danaher in the third quarter valued at about $25,000. Elevated Capital Advisors LLC purchased a new position in Danaher in the fourth quarter valued at about $26,000. WFA of San Diego LLC purchased a new position in Danaher in the second quarter valued at about $26,000. Finally, ANTIPODES PARTNERS Ltd purchased a new position in Danaher in the third quarter valued at about $27,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Danaher Stock Performance
DHR stock opened at $161.95 on Wednesday. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. The business’s fifty day simple moving average is $186.30 and its two-hundred day simple moving average is $210.30. Danaher has a twelve month low of $160.93 and a twelve month high of $242.80. The firm has a market cap of $114.62 billion, a price-to-earnings ratio of 31.32, a PEG ratio of 2.16 and a beta of 0.81.
Danaher (NYSE:DHR – Get Free Report) last released its earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. During the same quarter last year, the firm posted $1.88 earnings per share. The business’s revenue was up 3.7% compared to the same quarter last year. Analysts predict that Danaher will post 8.43 earnings per share for the current year.
Danaher Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a dividend of $0.40 per share. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a dividend yield of 1.0%. Danaher’s dividend payout ratio (DPR) is currently 30.95%.
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
See Also
- Five stocks we like better than Danaher
- Robinhood, SoFi, and Webull Are Telling Very Different Stories
- As Broadcom Eclipses $2 Trillion, Private Credit Giants Wants In
- Target the Red-Hot Spin-Off and Merger Space With These ETFs
- Samsung Joins the $1 Trillion Club as AI Memory Demand Explodes
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
